Citation Impact
Citing Papers
Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson´s disease patients with motor complications
2010
Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008
2008 Standout
Practice Parameter: Treatment of Parkinson disease with motor fluctuations and dyskinesia (an evidence-based review): [RETIRED]
2006
A controlled trial of antidepressants in patients with Parkinson disease and depression
2008
Psychiatric Complications in Parkinson Disease
2005
Glutamate receptor ion channels
2005 Standout
The American Urological Association Symptom Index for Benign Prostatic Hyperplasia
1992 Standout
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
The neuropathological basis for depression in Parkinson's disease
2008
Parkinson disease
2017 Standout
Antiepileptic drugs—best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies
2008
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Genetic basis for individual variations in pain perception and the development of a chronic pain condition
2004 Standout
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
2009 Standout
Treatment of Parkinson's disease
2000
Parkinson's disease: The quintessential neuropsychiatric disorder
2011
Is depression in Parkinson's Disease (PD) a specific entity?
2011
Adenosine receptors as therapeutic targets
2006 Standout
Randomized trial of the adenosine A 2A receptor antagonist istradefylline in advanced PD
2003
Albumin–drug interaction and its clinical implication
2013 Standout
A community-based epidemiological survey of female urinary incontinence:
2000 Standout
Ageing as a risk factor for neurodegenerative disease
2019 Standout
A systematic review of prevalence studies of depression in Parkinson's disease
2007 Standout
Kinetics and Crystal Structure of Catechol-O-Methyltransferase Complex with Co-Substrate and a Novel Inhibitor with Potential Therapeutic Application
2002
Parkinson's disease
2009 Standout
Frequency of levodopa‐related dyskinesias and motor fluctuations as estimated from the cumulative literature
2001
Checking consistency in mixed treatment comparison meta‐analysis
2010 Standout
Psychiatric outcome studies (POS): Does treatment help the patients? A Popperian approach to research in clinical psychiatry
2007
Psychotic symptoms in Parkinson’s disease
2005
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Canadian guideline for Parkinson disease
2019 Standout
Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation
2005
Parkinson's disease
2015 Standout
Circle of Willis atherosclerosis: association with Alzheimer’s disease, neuritic plaques and neurofibrillary tangles
2006
Catechol-O-Methyltransferase Inhibitors in Parkinson’s Disease
2015
The New Antiepileptic Drugs
2004
Effect of the catechol‐O‐methyltransferase inhibitor entacapone on the steady‐state pharmacokinetics and pharmacodynamics of warfarin
2002
Treatment of Cognitive, Psychiatric, and Affective Disorders Associated with Parkinson's Disease
2013
Neurotransmitter deficits in a non-multi-infarct category of vascular dementia
1989
Evidence‐Based Efficacy Comparison of Tolcapone and Entacapone as Adjunctive Therapy in Parkinson's Disease
2008
Cerebral Arterial Pulsation Drives Paravascular CSF–Interstitial Fluid Exchange in the Murine Brain
2013 Standout
Treatment interventions for Parkinson's disease: an evidence based assessment
2002
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
2004 Standout
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
2007 Standout
Systematic Overview of Warfarin and Its Drug and Food Interactions
2005 Standout
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease
2004 Standout
Depressive symptom profile in Parkinson's disease: a comparison with depression in elderly patients without Parkinson's disease
2006
Non-motor features of Parkinson disease
2017 Standout
Current approaches to management of depression in Parkinson’s Disease
2005
The American Urological Association Symptom Index for Benign Prostatic Hyperplasia
2016 Standout
Newer Anticonvulsants
2000
Post-Traumatic Growth After a Myocardial Infarction: A Matter of Personality, Psychological Health, or Cognitive Coping?
2008 Standout
Psychosis, apathy, depression and anxiety in Parkinson's disease
2012
The Pathophysiology of Urinary Incontinence among Institutionalized Elderly Persons
1989
Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options
2009 Standout
Short‐term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing‐off phenomenon
2003
Levodopa/carbidopa/entacapone in Parkinson’s disease
2009
Systematic review of levodopa dose equivalency reporting in Parkinson's disease
2010 Standout
A systematic review of prevalence studies of dementia in Parkinson's disease
2005 Standout
SPECT imaging of the dopamine transporter with [123I]-β-CIT reveals marked decline of nigrostriatal dopaminergic function in Parkinson's disease with urinary dysfunction
2001
Neurodegenerative diseases and oxidative stress
2004 Standout
The Pathobiology of Vascular Dementia
2013 Standout
Hypothalamic monoamines and neuropeptides in dementia
1991 StandoutNobel
Citalopram for major depressive disorder in adults: a systematic review and meta-analysis of published placebo-controlled trials
2011
Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring
2014 StandoutNobel
Crystallization and preliminary crystallographic characterization of catechol-O-methyltransferase in complex with its cosubstrate and an inhibitor
2001
Clinical Pharmacology, Therapeutic Use and Potential of COMT Inhibitors in Parkinson???s Disease
2000
The WHO-5 Well-Being Index: A Systematic Review of the Literature
2015 Standout
Depression in Older Adults
2009 Standout
CADASIL
2009 Standout
Value of postvoid residual urine determination in evaluation of prostatism
1982
Ropinirole 24-hour prolonged release
2007
Applicability and validity of the Major Depression Inventory in patients with Parkinson's disease
1998
Clinical and Cystometric Characteristics of Continent and Incontinent Noninstitutionalized Elderly
1988
Management of Parkinson's disease: An evidence-based review
2002
Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women
2014 Standout
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
2012 Standout
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Pharmacological interventions for somatoform disorders in adults
2014 Standout
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
2011
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Shared Risk Factors for Falls, Incontinence, and Functional Dependence
1995 Standout
The Binding of Drugs by Plasma Proteins
1968
Citalopram versus other anti-depressive agents for depression
2012
Gut microbiota are related to Parkinson's disease and clinical phenotype
2014 Standout
Perivascular deposits of serum proteins in cerebral cortex in vascular dementia
1985
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Catechol-O-methyltransferase (COMT): Biochemistry, Molecular Biology, Pharmacology, and Clinical Efficacy of the New Selective COMT Inhibitors
1999
Evidence-Based Efficacy Comparison of Tolcapone and Entacapone as Adjunctive Therapy in Parkinson's Disease
2008
Clinical pharmacology and therapeutic use of COMT inhibition in Parkinson's disease
2007
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
Hereditary multi-infarct dementia
1977
Haben Neuroleptika eine analgetische Potenz?
1998
Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
2008 Standout
Psychiatric Complications in Parkinson Disease
2005
Recognition and Treatment of Depression in Parkinson's Disease
2003
Electrical stimulation for preventing and treating post-stroke shoulder pain: a systematic Cochrane review
2001
Industry sponsorship and research outcome
2017 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Works of J Worm-Petersen being referenced
Therapeutic experiences with 947 epileptic out-patients in oxcarbazepine treatment
2009
Sustained-release Madopar HBS® compared with standard Madopar® in the long-term treatment of de novo parkinsonian patients
2009
The tolerability and efficacy of entacapone over 3 years in patients with Parkinson's disease
2003
The levodopa dose‐sparing capacity of pergolide compared with that of bromocriptine in an open‐label, crossover study
1996
ATHEROSCLEROSIS OF CEREBRAL ARTERIES, PATHOLOGICAL AND CLINICAL CORRELATIONS
2009
DISTURBANCES of MICTURITION IN PARKINSON'S DISEASE
1976
The Binding of Vitamin B12 Added in Vitro and in Vivo to Normal Human Serum Proteins Separated on Ion Exchange Cellulose
1965
Entacapone enhances the response to levodopa in parkinsonian patients with motor fluctuations
1998
Postherpetic neuralgia treated with flupenthixol and citalopram
1984
Depression in idiopathic Parkinson's disease treated with citalopram: A placebo-controlled trial
1998
Atherosclerosis of Cerebral Arteries, Pathological and Clinical Correlations
1968
Bladder Function in Healthy Elderly Males
1978
The levodopa dose-sparing capacity of pergolide compared with that of bromocriptine
1996